Current status and prevention strategies for respiratory virus infections after lung transplantation
10.3969/j.issn.1674-7445.2024123
- VernacularTitle:肺移植术后呼吸道病毒感染的研究现状及防治策略
- Author:
Min XIONG
1
;
Xiaoshan LI
1
;
Ting QIAN
1
;
Lin MAN
1
;
Hang YANG
1
;
Jingyu CHEN
1
;
Bo WU
1
Author Information
1. Wuxi Medical Center, Nanjing Medical University, Wuxi People's Hospital, Lung Transplant Center, the Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi 214023, China.
- Publication Type:ReviewArticle
- Keywords:
Lung transplantation;
Respiratory virus;
Infection;
Cytomegalovirus;
Epstein-Barr virus;
Influenza virus;
Respiratory syncytial virus;
Adenovirus
- From:
Organ Transplantation
2024;15(6):970-976
- CountryChina
- Language:Chinese
-
Abstract:
Lung transplantation is an effective means of treating various end-stage lung diseases. However, compared with other solid organ transplants, the survival rate after lung transplantation is relatively low. The main reason is the numerous complications after lung transplantation, among which infection is one of the most common complications. Respiratory viral infections are an important type of infection after lung transplantation, which severely affect the survival time and quality of life of lung transplant recipients. Early identification, early prevention, and active diagnosis and treatment are of great significance in reducing the incidence and fatality of respiratory viral infections after lung transplantation. This article reviews the epidemiology, risk factors, prevention and treatment principles, and specific prevention and treatment progress of common viruses in respiratory viral infections after lung transplantation at home and abroad, in order to provide a reference for the prevention and treatment of respiratory viral infections after lung transplantation in clinical practice.
